Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
expression is regulated by testosterone [RGD, Feb 2006].. Additionally we are shipping SCGB2A1 Antibodies (66) and SCGB2A1 Kits (6) and many more products for this protein.
Showing 5 out of 5 products:
The expression of HOXB13 (show HOXB13 Proteins), IL17BR, and mammaglobin 1 (show SCGB2A2 Proteins) in sentinel lymph nodes predict the outcome of primary breast cancer patients.
novel marker GATA3 (show GATA3 Proteins) stains a significantly higher proportion of both primary and metastatic breast carcinomas than GCDFP15 (show PIP Proteins) or mammaglobin with stronger and more diffuse staining, helpful in cases with small tissue samples
The commonly used breast carcinoma biomarkers vary in their prognostic implications. GCDFP-15 (show PIP Proteins) independently indicated a favourable prognosis. GATA-3 (show GATA3 Proteins) and MGB were not associated with outcome.
Results indicate that the quantitative analysis of h-MAM mRNA is a useful tool for detecting CTCs in breast cancer patients.
Results indicated that SCGB2A1 represented a novel, prognostic factor for colorectal cancer, and its expression correlated with chemoresistance, radioresistance and cancer cell stemness.
The data indicate that MGB1, MGB2 and LIPB mRNAs are expressed at low levels in human tissues but basal expression is upregulated in ovarian cancer.
SCGB2A1 is a top differentially expressed gene in all major histological types of ovarian cancers.
MGB has the highest expression in HER2 (show ERBB2 Proteins)-overexpressing breast cancers and may be a potentially useful marker for this subtype.
Data show that plasma mammaglobin mRNA alone or in combination with CA15.3 (CD227 (show MUC1 Proteins)) may be used as a valuable noninvasive approach for the diagnosis and the detection of metastasis in breast cancer at the time of diagnosis.
The mammaglobin/lipophilin B (show SCGB1D2 Proteins) complex is a promising diagnostic marker for breast cancer.
expression is regulated by testosterone
secretoglobin, family 2A, member 1
, lipophilin C
, mammaglobin 2
, mammaglobin B
, androgen receptor DNA-binding domain DNA
, prostatic steroid binding protein 1
, prostatic steroid binding protein, allele C3(2)
, prostatic steroid-binding protein 1
, prostatic steroid-binding protein C3.2
, secretoglobin family 2A member 1